News


All News

Patients who have inflammatory bowel disease (IBD) are at an increased risk of melanoma, according to study results presented recently.

New knowledge regarding rosacea’s pathology may explain why some newer treatment strategies appear effective, while pointing the way for additional approaches, according to an expert who spoke at the American Academy of Dermatology’s annual meeting.

Recent developments in tanning bed restrictions as well as improved sunscreen testing and labeling have raised the stakes in the ongoing battle against melanoma.

New and cutting edge technologies are proving useful for clinical diagnosis and early detection of melanoma. Depending on the diagnostic tool used, clinicians can improve their assessment of suspicious lesions and better evaluate the fine nuances differentiating benign and malignant pigmented lesions.

Filler procedures have become a staple in the dermatologic armamentarium for the treatment of numerous cosmetic indications, allowing physicians to perform sophisticated soft tissue augmentation procedures in their patients, safely and effectively. Though the correction of nasolabial folds was the first and perhaps the most popular indication for fillers, nontraditional areas where these cosmetic tools can be implemented are ever growing.

The FDA approved two drugs and a companion diagnostic for the treatment of advanced metastatic melanoma Wednesday, the organization announced.

The U.S. Food and Drug Administration (FDA) announced this morning that Sandoz is conducting a voluntary recall of its Methotrexate Sodium USP, 25 mg/mL, 40 mL injectable products. The manufacturer discovered particulate matter in vials during a routine quality inspection of retention samples.

Cutaneous squamous cell carcinomas typically are easily cured with surgery or ablation, but in certain patients with disease risk factors, the cancer can result in death, according to study findings.

Older patients who have nonmelanoma skin cancer (NMSC) may have a significantly lower risk of developing Alzheimer’s disease, a recent study indicates.

Sun exposure may help to reduce blood pressure, demonstrating that the benefits of exposure to UV rays may be greater than the risk of getting skin cancer, according to a proof-of-principle study.

The Food and Drug Administration is proposing that indoor tanning beds be labeled with warnings to notify users about the risks of developing skin cancer from the devices.

A novel compound reduces oxidative stress that results in the loss of pigment in hair, signaling a potential treatment breakthrough for gray hair and vitiligo, according to results of a study.